1
|
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.
|
J Med Chem
|
2013
|
0.97
|
2
|
Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
|
J Med Chem
|
2014
|
0.89
|
3
|
Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.
|
J Med Chem
|
2013
|
0.88
|
4
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|